Ar-Ex Laboratories Pvt Ltd is a professional and research based pharmaceutical company having Pan-India presence. Ar-Ex is operating in Gynec Therapy Segment Pan-India with hi-tech products. The company is totally managed by well experienced professionals.
Ar-Ex has been in operation over five decades in India and has been serving the medical fraternity of India with best in class Gynec Speciality Products.
Researchers from the Laboratory of Cancer Metabolism at IDIBELL found a potential target for the treatment of type 2 diabetes. The study is published in the Journal of Clinical Investigation. Research led by Sara Kozma, have shown in animal models that inhibition of S6K1 protein may be a potential treatment for type 2 diabetes.


